Table of Contents
1 Industry Overview of Skin Disease Treatment Technologies
 1.1 Definition and Specifications of Skin Disease Treatment Technologies
    1.1.1 Definition of Skin Disease Treatment Technologies
    1.1.2 Specifications of Skin Disease Treatment Technologies
 1.2 Classification of Skin Disease Treatment Technologies
    1.2.1 Epidermis
    1.2.2 Basement Membrane
    1.2.3 Dermis
    1.2.4 Hypodermis
 1.3 Applications of Skin Disease Treatment Technologies
 1.4 Industry Chain Structure of Skin Disease Treatment Technologies
 1.5 Industry Overview and Major Regions Status of Skin Disease Treatment Technologies
    1.5.1 Industry Overview of Skin Disease Treatment Technologies
    1.5.2 Global Major Regions Status of Skin Disease Treatment Technologies
 1.6 Industry Policy Analysis of Skin Disease Treatment Technologies
 1.7 Industry News Analysis of Skin Disease Treatment Technologies2 Manufacturing Cost Structure Analysis of Skin Disease Treatment Technologies
 2.1 Raw Material Suppliers and Price Analysis of Skin Disease Treatment Technologies
 2.2 Equipment Suppliers and Price Analysis of Skin Disease Treatment Technologies
 2.3 Labor Cost Analysis of Skin Disease Treatment Technologies
 2.4 Other Costs Analysis of Skin Disease Treatment Technologies
 2.5 Manufacturing Cost Structure Analysis of Skin Disease Treatment Technologies
 2.6 Manufacturing Process Analysis of Skin Disease Treatment Technologies3 3 Global Market Size (Volume and Value), Sales and Sale Price Analysis of Skin Disease Treatment Technologies
 3.1 Global Market Size (Volume and Value) and Growth Rate of Skin Disease Treatment Technologies 2011-2018
 3.2 Global Market Size (Volume and Value) of Skin Disease Treatment Technologies by Regions 2011-2018
 3.3 Global Market Size (Volume and Value) of Skin Disease Treatment Technologies by Types 2011-2018
 3.4 Global Market Size (Volume and Value) of Skin Disease Treatment Technologies by Applications 2011-2018
 3.5 Global Sales Volume and Sales Revenue of Skin Disease Treatment Technologies by Companies 2011-2018
 3.6 Global Sale Price of Skin Disease Treatment Technologies by Regions 2011-2018
 3.7 Global Sale Price of Skin Disease Treatment Technologies by Types 2011-2018
 3.8 Global Sale Price of Skin Disease Treatment Technologies by Applications 2011-2018
 3.9 Global Sale Price of Skin Disease Treatment Technologies by Companies 2011-20184 USA Market Size (Volume and Value), Sales, Sale Price and End Users Analysis of Skin Disease Treatment Technologies
 4.1 USA Market Size (Volume and Value) and Growth Rate of Skin Disease Treatment Technologies 2011-2018
 4.2 USA Market Size (Volume and Value) of Skin Disease Treatment Technologies by Types 2011-2018
 4.3 USA Market Size (Volume and Value) of Skin Disease Treatment Technologies by Applications 2011-2018
 4.4 USA Sales Volume and Sales Revenue of Skin Disease Treatment Technologies by Companies 2011-2018
 4.5 USA Sale Price of Skin Disease Treatment Technologies by Types 2011-2018
 4.6 USA Sale Price of Skin Disease Treatment Technologies by Applications 2011-2018
 4.7 USA Sale Price of Skin Disease Treatment Technologies by Companies 2011-2018
 4.8 USA Regional Supply, Import, Export and Consumption of Skin Disease Treatment Technologies 2011-2018
 4.9 USA End Users with Contact Information and Consumption Volume of Skin Disease Treatment Technologies by Applications5 Europe Market Size (Volume and Value), Sales, Sale Price and End Users Analysis of Skin Disease Treatment Technologies
 5.1 Europe Market Size (Volume and Value) and Growth Rate of Skin Disease Treatment Technologies 2011-2018
 5.2 Europe Market Size (Volume and Value) of Skin Disease Treatment Technologies by Types 2011-2018
 5.3 Europe Market Size (Volume and Value) of Skin Disease Treatment Technologies by Applications 2011-2018
 5.4 Europe Sales Volume and Sales Revenue of Skin Disease Treatment Technologies by Companies 2011-2018
 5.5 Europe Sale Price of Skin Disease Treatment Technologies by Types 2011-2018
 5.6 Europe Sale Price of Skin Disease Treatment Technologies by Applications 2011-2018
 5.7 Europe Sale Price of Skin Disease Treatment Technologies by Companies 2011-2018
 5.8 Europe Regional Supply, Import, Export and Consumption of Skin Disease Treatment Technologies 2011-2018
 5.9 Europe End Users with Contact Information and Consumption Volume of Skin Disease Treatment Technologies by Applications6 China Market Size (Volume and Value), Sales, Sale Price and End Users Analysis of Skin Disease Treatment Technologies
 6.1 China Market Size (Volume and Value) and Growth Rate of Skin Disease Treatment Technologies 2011-2018
 6.2 China Market Size (Volume and Value) of Skin Disease Treatment Technologies by Types 2011-2018
 6.3 China Market Size (Volume and Value) of Skin Disease Treatment Technologies by Applications 2011-2018
 6.4 China Sales Volume and Sales Revenue of Skin Disease Treatment Technologies by Companies 2011-2018
 6.5 China Sale Price of Skin Disease Treatment Technologies by Types 2011-2018
 6.6 China Sale Price of Skin Disease Treatment Technologies by Applications 2011-2018
 6.7 China Sale Price of Skin Disease Treatment Technologies by Companies 2011-2018
 6.8 China Regional Supply, Import, Export and Consumption of Skin Disease Treatment Technologies 2011-2018
 6.9 China End Users with Contact Information and Consumption Volume of Skin Disease Treatment Technologies by Applications7 Japan Market Size (Volume and Value), Sales, Sale Price and End Users Analysis of Skin Disease Treatment Technologies
 7.1 Japan Market Size (Volume and Value) and Growth Rate of Skin Disease Treatment Technologies 2011-2018
 7.2 Japan Market Size (Volume and Value) of Skin Disease Treatment Technologies by Types 2011-2018
 7.3 Japan Market Size (Volume and Value) of Skin Disease Treatment Technologies by Applications 2011-2018
 7.4 Japan Sales Volume and Sales Revenue of Skin Disease Treatment Technologies by Companies 2011-2018
 7.5 Japan Sale Price of Skin Disease Treatment Technologies by Types 2011-2018
 7.6 Japan Sale Price of Skin Disease Treatment Technologies by Applications 2011-2018
 7.7 Japan Sale Price of Skin Disease Treatment Technologies by Companies 2011-2018
 7.8 Japan Regional Supply, Import, Export and Consumption of Skin Disease Treatment Technologies 2011-2018
 7.9 Japan End Users with Contact Information and Consumption Volume of Skin Disease Treatment Technologies by Applications8 Major Manufacturers Analysis of Skin Disease Treatment Technologies
 8.1 ABBVIE
    8.1.1 Company Profile
    8.1.2 Product Picture and Specifications
        8.1.2.1 Type I
        8.1.2.2 Type II
        8.1.2.3 Type III
    8.1.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.1.4 Contact Information 8.2 AGENUS
    8.2.1 Company Profile
    8.2.2 Product Picture and Specifications
        8.2.2.1 Type I
        8.2.2.2 Type II
        8.2.2.3 Type III
    8.2.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.2.4 Contact Information
    8.3 AICURIS GMBH & CO. KG
    8.3.1 Company Profile
    8.3.2 Product Picture and Specifications
        8.3.2.1 Type I
        8.3.2.2 Type II
        8.3.2.3 Type III
    8.3.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.3.4 Contact Information
 8.4 ALLERGAN
    8.4.1 Company Profile
    8.4.2 Product Picture and Specifications
        8.4.2.1 Type I
        8.4.2.2 Type II
        8.4.2.3 Type III
    8.4.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.4.4 Contact Information
 8.5 ALMIRALL
    8.5.1 Company Profile
    8.5.2 Product Picture and Specifications
        8.5.2.1 Type I
        8.5.2.2 Type II
        8.5.2.3 Type III
    8.5.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.5.4 Contact Information
 8.6 AMGEN
    8.6.1 Company Profile
    8.6.2 Product Picture and Specifications
        8.6.2.1 Type I
        8.6.2.2 Type II
        8.6.2.3 Type III
    8.6.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.6.4 Contact Information
    8.7 ANACOR PHARMACEUTICALS INC.
    8.7.1 Company Profile
    8.7.2 Product Picture and Specifications
        8.7.2.1 Type I
        8.7.2.2 Type II
        8.7.2.3 Type III
    8.7.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.7.4 Contact Information
 8.8 ANGES MG
    8.8.1 Company Profile
    8.8.2 Product Picture and Specifications
        8.8.2.1 Type I
        8.8.2.2 Type II
        8.8.2.3 Type III
    8.8.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.8.4 Contact Information
 8.9 APEIRON BIOLOGICS AG
    8.9.1 Company Profile
    8.9.2 Product Picture and Specifications
        8.9.2.1 Type I
        8.9.2.2 Type II
        8.9.2.3 Type III
    8.9.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.9.4 Contact Information
    8.10 ASTELLAS PHARMA INC.
    8.10.1 Company Profile
    8.10.2 Product Picture and Specifications
        8.10.2.1 Type I
        8.10.2.2 Type II
        8.10.2.3 Type III
    8.10.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.10.4 Contact Information
 8.11 ASTION PHARMA A/S
    8.11.1 Company Profile
    8.11.2 Product Picture and Specifications
        8.11.2.1 Type I
        8.11.2.2 Type II
        8.11.2.3 Type III
    8.11.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.11.4 Contact Information
 8.12 ASTRAZENECA
    8.12.1 Company Profile
    8.12.2 Product Picture and Specifications
        8.12.2.1 Type I
        8.12.2.2 Type II
        8.12.2.3 Type III
    8.12.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.12.4 Contact Information
 8.13 BARRIER THERAPEUTICS
    8.13.1 Company Profile
    8.13.2 Product Picture and Specifications
        8.13.2.1 Type I
        8.13.2.2 Type II
        8.13.2.3 Type III
    8.13.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.13.4 Contact Information
    8.14 BASILEA PHARMACEUTICA LTD.
    8.14.1 Company Profile
    8.14.2 Product Picture and Specifications
        8.14.2.1 Type I
        8.14.2.2 Type II
        8.14.2.3 Type III
    8.14.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.14.4 Contact Information
 8.15 BRISTOL-MYERS SQUIBB
    8.15.1 Company Profile
    8.15.2 Product Picture and Specifications
        8.15.2.1 Type I
        8.15.2.2 Type II
        8.15.2.3 Type III
    8.15.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.15.4 Contact Information
 8.16 CELGENE
    8.16.1 Company Profile
    8.16.2 Product Picture and Specifications
        8.16.2.1 Type I
        8.16.2.2 Type II
        8.16.2.3 Type III
    8.16.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.16.4 Contact Information
 8.17 CIPHER PHARMACEUTICALS
    8.17.1 Company Profile
    8.17.2 Product Picture and Specifications
        8.17.2.1 Type I
        8.17.2.2 Type II
        8.17.2.3 Type III
    8.17.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.17.4 Contact Information
    8.18 DUSA PHARMACEUTICALS INC.
    8.18.1 Company Profile
    8.18.2 Product Picture and Specifications
        8.18.2.1 Type I
        8.18.2.2 Type II
        8.18.2.3 Type III
    8.18.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.18.4 Contact Information
 8.19 ELI LILLY
    8.19.1 Company Profile
    8.19.2 Product Picture and Specifications
        8.19.2.1 Type I
        8.19.2.2 Type II
        8.19.2.3 Type III
    8.19.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.19.4 Contact Information
 8.20 GALDERMA PHARMA SA/GALDERMA SA
    8.20.1 Company Profile
    8.20.2 Product Picture and Specifications
        8.20.2.1 Type I
        8.20.2.2 Type II
        8.20.2.3 Type III
    8.20.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.20.4 Contact Information
 8.21 GENENTECH
    8.21.1 Company Profile
    8.21.2 Product Picture and Specifications
        8.21.2.1 Type I
        8.21.2.2 Type II
        8.21.2.3 Type III
    8.21.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.21.4 Contact Information
 8.22 GLAXOSMITHKLINE
    8.22.1 Company Profile
    8.22.2 Product Picture and Specifications
        8.22.2.1 Type I
        8.22.2.2 Type II
        8.22.2.3 Type III
    8.22.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.22.4 Contact Information
 8.23 HANALL BIOPHARMA
    8.23.1 Company Profile
    8.23.2 Product Picture and Specifications
        8.23.2.1 Type I
        8.23.2.2 Type II
        8.23.2.3 Type III
    8.23.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.23.4 Contact Information
 8.24 IMMUNE TECHNOLOGIES & MEDICINE
    8.24.1 Company Profile
    8.24.2 Product Picture and Specifications
        8.24.2.1 Type I
        8.24.2.2 Type II
        8.24.2.3 Type III
    8.24.3 Capacity, Production, Price, Cost, Gross and Revenue
    8.24.4 Contact Information
9 Global Production Analysis of Skin Disease Treatment Technologies by Regions
 9.1 Global Production of Skin Disease Treatment Technologies by Regions 2011-2018
 9.2 Global Production Market Share of Skin Disease Treatment Technologies by Regions 2011-201810 Global and Major Regions Market Size (Volume and Value) Forecast of Skin Disease Treatment Technologies
 10.1 Global and Major Regions Market Size (Volume and Value) and Growth Rate of Skin Disease Treatment Technologies 2018-2023
 10.2 Global Market Size (Volume and Value) of Skin Disease Treatment Technologies by Regions 2018-2023
 10.3 Global and Major Regions Market Size (Volume and Value) of Skin Disease Treatment Technologies by Types 2018-2023
 10.4 Global and Major Regions Market Size (Volume and Value) of Skin Disease Treatment Technologies by Applications 2018-202311 Marketing Trader or Distributor Analysis of Skin Disease Treatment Technologies
 11.1 Marketing Channels Status of Skin Disease Treatment Technologies
 11.2 Traders or Distributors with Contact Information of Skin Disease Treatment Technologies by Regions
 11.3 Regional Import, Export and Trade Analysis of Skin Disease Treatment Technologies12 New Project Investment Feasibility Analysis of Skin Disease Treatment Technologies
 12.1 New Project SWOT Analysis of Skin Disease Treatment Technologies
 12.2 New Project Investment Feasibility Analysis of Skin Disease Treatment Technologies13 Conclusion of the Global Skin Disease Treatment Technologies Consumption 2018 Market Research Report